Biotech

All Articles

Vaderis' uncommon blood vessel condition medication minimizes nosebleeds

.Vaderis Therapeutics' objective to establish the initial medication targeted especially at a specif...

Navigator brings up $100M to build new autoimmune pipe

.Navigator Medicines has outfitted on its own with $100 million in set A funds as the youthful biote...

Duality seeks money for ADC tests as IPO wave infects Asia

.China's Duplicity Biotherapeutics has filed (PDF) documentation for a Hong Kong IPO, finding an und...

YolTech offers China rights to gene editing therapy for $29M

.4 months after Chinese gene editing provider YolTech Therapies took its own cholesterol levels dise...

Addex sell rises after Indivior offers up to $300M for substance

.Indivior is actually getting a small molecule allosteric modulator made to manage material make use...

Molecular Partners tweaks AML test over 'suboptimal visibility'

.Molecular Companions has recognized "suboptimal visibility" to its own tetra-specific T-cell engage...

Despite combined market, an equity capital resurgence could be being available in Europe: PitchBook

.While the biotech assets scene in Europe has reduced relatively observing a COVID-19 financing boom...

8 months after a $213M fundraise, genetics publisher Volume makes reduces

.After rearing $213 million in 2023-- one of the year's biggest exclusive biotech shots-- Tome Biosc...

BioMarin develops exec group with biotech veterinarians-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, firings a...

Biopharma Q2 VC hit highest level considering that '22, while M&ampA reduced

.Financial backing financing into biopharma cheered $9.2 billion around 215 sell the second fourth o...